Raising Capital Through a Public Offering and Third-Party Allotment
First written in FY2022-Q1. 8 of 9 entries say "Advanced", first in FY2022-Q2. Latest entry: FY2024-Q3.
6 other companies' latest entry also says "Advanced".
- FY2024-Q3AdvancedAnnual report
「Between 1 January 2024 and 31 January 2024, the exercise of share acquisition rights increased the total number of shares issued by 130,400 and increased the balances of stated capital and capital reserves by ¥10.679 million each.」
The exercise of share acquisition rights after the quarter-end increased the total number of shares issued by 130,400 and stated capital and capital reserves by ¥10.679 million each. - FY2023AdvancedAnnual report
「The exercise of stock options increased stated capital and capital surplus by ¥27.664 million each.」
The exercise of share acquisition rights continued during the fiscal year, increasing stated capital and capital surplus by ¥27.664 million each. - FY2023-Q3AdvancedAnnual report
「This was mainly attributable to increases of ¥14.984 million in both stated capital and capital surplus resulting from the exercise of stock options, and an increase of ¥489.497 million in retained earnings.」
The exercise of stock options continued during the cumulative third quarter, increasing stated capital and capital surplus by ¥14.984 million each. - FY2023-Q2AdvancedAnnual report
「This was mainly attributable to increases of ¥12.484 million in both stated capital and capital surplus resulting from the exercise of stock options, and an increase of ¥310.868 million in retained earnings.」
Stock options were exercised during the cumulative second quarter, increasing stated capital and capital surplus by ¥12.484 million each. - FY2023-Q1AdvancedAnnual report
「This was mainly attributable to increases of ¥7.455 million each in stated capital and capital surplus resulting from the exercise of stock options, and an increase of ¥41.126 million in retained earnings.」
Stock options were exercised during the first quarter, increasing stated capital and capital surplus by ¥7.455 million each. - FY2022AdvancedAnnual report
「Public offerings, third-party allotments and the exercise of stock options resulted in increases of ¥517.442 million each in stated capital and capital surplus.」
Including the public offering, the third-party allotment related to the over-allotment and the exercise of stock options, stated capital and capital surplus each increased by ¥517.442 million during the fiscal year. Cash inflows from financing activities through the issuance of shares were ¥1,025.241 million. - FY2022-Q3AdvancedAnnual report
「The issuance of new shares through a public offering with a payment date of 6 April 2021 increased stated capital and capital surplus by ¥276.000 million each during the cumulative third quarter of the current consolidated fiscal year. In addition, the issuance of new shares through a third-party allotment related to the over-allotment offering with a payment date of 26 April 2021 increased stated capital and capital surplus by ¥211.692 million each during the same period. As a result, including increases from the exercise of share acquisition rights (stock options), stated capital and capital surplus increased by ¥511.442 million each during the cumulative third quarter of the current consolidated fiscal year. At the end of the third quarter of the current consolidated fiscal year, stated capital was ¥611.442 million and capital surplus was ¥550.462 million.」
The cumulative amount of capital raised, including the public offering, the third-party allotment related to the over-allotment and the exercise of stock options, was updated, with stated capital and capital surplus each increasing by ¥511.442 million. - FY2022-Q2AdvancedAnnual report
「The issuance of new shares through a public offering with a payment date of 6 April 2021 increased stated capital and capital surplus by ¥276.000 million each during the cumulative second quarter of the current consolidated fiscal year. In addition, the issuance of new shares through a third-party allotment related to the over-allotment offering with a payment date of 26 April 2021 increased stated capital and capital surplus by ¥211.692 million each during the same period.」
The payment dates and amounts of the increases from the public offering and the third-party allotment related to the over-allotment were specified. Including the exercise of stock options, stated capital and capital surplus each increased by ¥505.442 million. - FY2022-Q1First statedAnnual report
「Public offerings, third-party allotments and the exercise of stock options resulted in increases of ¥496.317 million each in stated capital and capital surplus.」
Stated capital and capital surplus increased through public offerings, third-party allotments and the exercise of stock options.